The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.

Sanders, Jan‐Stephan; J. Bemelman, Fréderike; Lianne Messchendorp, A.; C. Baan, Carla; van Baarle, Debbie; van Binnendijk, Rob; A. Diavatopoulos, Dimitri; C. Frölke, Sophie; Geers, Daryl; H. GeurtsvanKessel, Corine; den Hartog, Gerco; van der Heiden, Marieke; Imhof, Céline; M. L. Kho, Marcia; Koopmans, Marion; Reshwan K. Malahe, S.; B. Mattheussens, Wouter; van der Molen, Renate; van Mourik, Djenolan; B. M. Remmerswaal, Ester; Y. Rots, Nynke; Vart, Priya; D. de Vries, Rory; T. Gansevoort, Ron; B. Hilbrands, Luuk; E. J. Reinders, Marlies

doi:10.1097/tp.0000000000003983

Public

The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.

Published in PubMed • Apr 1, 2022

Authors:

Jan‐Stephan Sanders

Fréderike J. Bemelman

A. Lianne Messchendorp

Abstract

BACKGROUND: In kidney patients COVID-19 is associated with severely increased morbidity and mortality. A comprehensive comparison of the immunogenicity, tolerability, and safety of COVID-19 vaccination in different cohorts of kidney patients and a control cohort is lacking. METHODS: This investigato...

Subject

Medicine

Dialysis

Seroconversion

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!